Skip to main content

Animations

MJFF Publications

2571 - 2580 of 6466 Results
Title
Year
  • Year
  • 2024
  • 2017
  • 2017
  • 2017
  • 2025
  • 2018
  • 2025
  • 2015
  • 2021
  • 2025
  • Summary Details
    OPEN
    Title: USP14 inhibition enhances Parkin-independent mitophagy in iNeurons
    Journal Name: Pharmacological Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.phrs.2024.107484
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Unraveling the Biologic Basis for Domain-Specific Cognitive Decline
    Journal Name: The American Journal of Geriatric Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jagp.2017.04.007
    Citation Count: 1
  • Summary Details
    OPEN
    Title: A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.27259
    Citation Count: 19
  • The Kinase Fyn As a Novel Intermediate in l-DOPA-Induced Dyskinesia in Parkinson’s Disease
    2017
    Summary Details
    OPEN
    Title: The Kinase Fyn As a Novel Intermediate in l-DOPA-Induced Dyskinesia in Parkinson’s Disease
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s12035-017-0748-3
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Diplopia in the Spinocerebellar Ataxias: Prevalence, Risk Factors, and Association with Falls
    Journal Name: Neuro-Ophthalmology
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/01658107.2025.2468446
    Citation Count: 0
  • Summary Details
    OPEN
    Title: α‐Synuclein stimulation of monoamine oxidase‐B and legumain protease mediates the pathology of Parkinson's disease
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.15252/embj.201798878
    Citation Count: 97
  • Summary Details
    OPEN
    Title: Autophagy and mitophagy at the synapse and beyond: implications for learning, memory and neurological disorders
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/15548627.2025.2581217
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Dual κ‐agonist/μ‐antagonist opioid receptor modulation reduces levodopa‐induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model ofParkinson disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24375
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Genome-wide association study and functional validation implicates JADE1 in tauopathy
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-021-02379-z
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Genetic modulation of mitochondrial NAD+ regeneration does not prevent dopaminergic neuron dysfunction caused by mitochondrial complex I impairment
    Journal Name: Frontiers in Cell and Developmental Biology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fcell.2025.1650462
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.